Fda Advisory Committee

185th Meeting of Vaccines and Related Biological Products Advisory Committee

U.S. Food and Drug Administration

June 10, 2024 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee (PCNS)

U.S. Food and Drug Administration

June 4, 2024 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)

U.S. Food and Drug Administration

May 24, 2024 Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting

U.S. Food and Drug Administration

March 14, 2024 Meeting of the Oncologic Drugs Advisory Committee (ODAC)

U.S. Food and Drug Administration

April 12, 2024 Meeting of the Oncologic Drugs Advisory Committee (ODAC)

U.S. Food and Drug Administration

March 15, 2024 Meeting of the Oncologic Drugs Advisory Committee (ODAC)

U.S. Food and Drug Administration

Public Meeting: Optimizing FDA’s Use of and Processes for Advisory Committees (Afternoon Portion)

U.S. Food and Drug Administration

FDA Advisory committee doctors discuss opioid labeling

Oncologic Drugs Advisory Committee Meeting

U.S. Food and Drug Administration

Meeting of the Oncologic Drugs Advisory Committee (ODAC)

U.S. Food and Drug Administration

Public Meeting: Optimizing FDA’s Use of and Processes for Advisory Committees (Morning Portion)

U.S. Food and Drug Administration

November 16, 2023 Meeting of the Oncologic Drugs Advisory Committee (ODAC)

U.S. Food and Drug Administration

Intro to FDA Advisory Committee meetings: aducanumab's AdComm

February 9, 2023 Meeting of the Oncologic Drugs Advisory Committee (ODAC)

U.S. Food and Drug Administration

76th Cellular, Tissue, and Gene Therapies Advisory Committee

U.S. Food and Drug Administration

125th Meeting of the Blood Products Advisory Committee (BPAC)

U.S. Food and Drug Administration

WATCH LIVE: FDA advisory panel reviews MDMA-drug ‘ecstasy’ to treat PTSD

75th Cellular, Tissue, and Gene Therapies Advisory Committee

U.S. Food and Drug Administration